Antidiabetic effect of 1-deazapurines derivatives with alpha-glucosidase Enzyme: A molecular tools approach
BOUKLI HACENE, F.; Cherrak, S. A.; Soufi, W.; Ghalem, S.
Show abstract
Alpha-glucosidase inhibition has been shown by several 1-deazapurine derivatives that have already been synthesized and evaluated in vitro, providing a potential treatment target for type 2 diabetes. Six of them were shown to have higher percentages of inhibition against the alpha-glucosidase enzyme and lower IC50 values. The binding mechanism and stability of the generated complexes are investigated in the current work using various molecular modeling methodologies. The ligands L17, L11, and L4 present the best binding energy with the establishment of interaction toward the site active, based on the results of the molecular docking simulation. The stability of the chosen complexes was then validated using molecular dynamics simulation. However, ADME-T prediction and Drug-likeness results show that these compounds have promising pharmacokinetic properties and oral bioavailability. Finally, these results imply that compounds L4 and L11 are very promising as a target for creating a lead molecule for type 2 diabetes.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 98%
- A program to automate the discovery of drugs for West Nile and Dengue virus -- programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling 97%
- Molecular Elucidation of Pancreatic Elastase Inhibition by Baicalein 97%
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 98%
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 98%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 98%
Similar papers in this journal
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 95%
- Primary Target Prediction of Bioactive Molecules from Chemical Structure 94%
- SAMbinder: A web server for predicting SAM binding residues of a protein from its amino acid sequence 94%
Similar papers in this journal
- Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal 96%
- Whole Genome Sequencing for Revealing the Point Mutations of SARS-CoV-2 Genome in Bangladeshi Isolates and their Structural Effects on Viral Proteins 93%
- Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay 92%
Similar papers in this journal
- Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design 98%
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 98%
- Cyclodextrin Derivative Enhances The Ophthalmic Delivery Of Poorly Soluble Azithromycin. 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.